A Risk Index and Data Display for Process Performance in the Pharmaceutical Industry

References

1. 1.↵
   ICH Harmonized Tripartite Guideline, Pharmaceutical Development Q8(R2), current step 4 version dated August 2009.
2. 2.↵
   1. Kotz S.,
   2. Johnson N. L.

   Process Capability Indices; Chapman & Hall: New York, 1993.
3. 3.↵
   1. Hyndman R. J.,
   2. Fan Y.

   Sample Quantiles in Statistical Packages. The American Statistician 1996, 50 (4), 4.

   OpenUrl
4. 4.↵
   1. Tukey J. W.

   Exploratory Data Analysis, 1st ed.; Addison-Wesley: Boston, MA, 1977.
5. 5.↵
   1. Montgomery D. C.

   Introduction to Statistical Quality Control, 6th ed.; John Wiley & Sons: Hoboken, NJ, 2009.
6. 6.↵
   1. Gunter B. H.

   The Use and Abuse of Cpk, Part 2. Quality Progress 1989, 22 (3), 108–109.

   OpenUrl
7. 7.↵
   1. Somerville S. E.,
   2. Montgomery D. C.

   Process Capability Indices and Non-Normal Distributions. Quality Engineering 1997, 9 (2), 305–316.

   OpenUrl
8. 8.↵
   1. Vannman K.,
   2. Albing M.

   Process Capability Indices for One-Sided Specification Intervals and Skewed Distributions. Quality and Reliability Engineering International 2007, 23 (6), 755–765.

   OpenUrl
9. 9.↵
   1. Clements J. A.

   Process capability calculations for non-normal distributions. Quality Progress 1989, 9.
10. 10.↵
    1. Pal S.

    Evaluation of Non-Normal Process Capability Indices Using Generalized Lambda Distribution. Quality Engineering 2005, 17 (1), 77–85.

    OpenUrl
11. 11.
    1. Chen J. P.,
    2. Ding C. G.

    A New Process Capability Index for Non-Normal Distributions. International Journal of Quality & Reliability Management 2001, 18 (7), 762–770.

    OpenUrlCrossRef